Ashleigh Palmer is the founder of Provention Bio. Provention Bio has raised $28M in total funding. Latest round: Series A.
Ashleigh Palmer is a co-founder and CEO of Provention Bio, a clinical-stage biopharmaceutical company focused on developing therapeutics for immune-mediated diseases. The company secured $28.4 million in founding financing to advance its mission of early disease interception and prevention.
Full founder directory · Investor directory · Company funding database · Fundraising library